baber/WOPTO huggingface dataset:
Patent NZ-593362-A (NZ)
Title: Modular digital camera
Inventor: JANNARD JAMES H
IPC: G03B19/00
Filed: 2009-12-22
Abstract: 593362 Disclosed is a modular motion camera (110). The modular motion camera (110) is comprised of a sensor module (112), a power module (124) and a recording module (120). The sensor module (112) has a surface which includes a first interface (138). The sensor module (112) includes an image sensor having a horizontal resolution of 2000 or more pixels. The sensor module (112) is configured to convert light received by the image sensor into digital motion picture image data at a rate of at least 23 frames per second. The power module (124) is comprised of a housing including a first surface having a second interface (142) and a second surface having a third interface (144). The power module (124) also has a bus segment, extending from the second interface (142) to the third interface (144), which includes a power bus configured to transmit power through the power module (124), and a data bus. The data bus is configured to transmit the motion picture image data having a horizontal resolution of 2000 or more pixels through the power module (124) at a frame rate of at least 23 frames per second. The recording module (120) has a housing including a first surface having a fourth interface (142) and a second surface having a fifth interface (144). The first interface (138) is functionally engageable with any of the second and fourth interfaces (142); the third interface (144) is functionally engageable with the fourth interface (142); and the second interface (142) is functionally engageable with the fifth interface (144). The power module (124) is configured to communicate, via the bus segment extending from the second interface (142) to the third interface (144), the motion picture image data having a horizontal resolution of 2000 or more pixels. The communicated motion picture image data is thereby recorded into the recording module (120) at a frame rate of at least 23 frames per second. Thus the modules may be arranged in a variety of ways using the coupling interfaces (142 and 144). Additional modules such as adapter modules (128) and I/O modules (126) may also be provided.
Patent NZ-595661-A (NZ)
Title: Method for purifying recombinant follicle stimulating hormone (fsh)
Inventor: SCHECKERMANN CHRISTIAN
IPC: C07K1/18
Filed: 2010-04-01
Abstract: NZ 595661 Disclosed is a method of purifying a recombinant follicle stimulating hormone (FSH) or recombinant FSH variant, comprising the steps of subjecting a liquid containing said FSH or FSH variant to: an anion exchange chromatography, a hydrophobic interaction chromatography, and a dye affinity chromatography. Each step of the method can be performed in any order and the method neither comprises a weak anion exchange chromatography nor a reverse phase chromatography.
Patent NZ-595854-A (NZ)
Title: Methods and compositions for treatment of bone defects with placental cell populations (ELOVL2, ST3GAL6, STGALNAC5, SLC12A8)
Inventor: EDINGER JAMES W
IPC: C12N5/074
Filed: 2007-10-23
Abstract: 595854 Disclosed is the use of a population of isolated placental stem cells in the manufacture of a medicament for the treatment of a bone defect in a human individual, wherein the bone defect is an osteolytic lesion associated with cancer, a bone fracture, or a spine in need of fusion, wherein said placental stem cells are present in an amount sufficient to treat said bone defect, wherein said placental stem cells express genes at a detectably higher level than an equivalent number of bone marrow-derived mesenchymal stem cells (BM-MSCs), wherein said genes comprise ELOVL2, ST3GAL6, ST6GALNAC5, or SLC12A8, and wherein said placental stem cells are not human totipotent cells.
Patent NZ-596626-A (NZ)
Title: Synthesis of sialic acid in plants
Inventor: PACCALET THOMAS
IPC: A61K38/14
Filed: 2007-02-09
Abstract: 596626 Synthesis of sialic acid in plants Provided is a method of synthesizing sialic acid comprising, i) providing a transgenic plant comprising a nucleotide sequence encoding microbial NeuSAc lyase, the nucleotide sequence operatively linked with a regulatory region that is active in the plant, and ii) growing the transgenic plant and expressing the nucleotide sequence thereby synthesizing sialic acid. The transgenic plants can be used to produce sialylated proteins of interest for oral therapeutics.
Patent NZ-598430-A (NZ)
Title: A method for determining structural parameters of composite building panels
Inventor: KENNEDY ARTHUR
IPC: E04C2/04
Filed: 2010-08-13
Abstract: A method of determining face paper properties of wallboard including providing a core strength value of the wallboard, determining a required nail pull value based the wallboard specifications and calculating a face paper stiffness value based on the provided core strength value and the determined nail pull value. The method includes displaying the calculated face paper stiffness value on a display device.
Patent NZ-598759-A (NZ)
Title: Lockable enclosure
Inventor: HACKER DEAN D
IPC: E05B15/00
Filed: 2010-09-21
Abstract: 598759 Disclosed is a locking arrangement which includes a latch assembly movable between a latching position and an unlatching position; a locking mechanism configured to hold the latch assembly in the latching position when the locking mechanism is in a locked condition and to allow the latch assembly to move to the unlatching position when the locking mechanism is in an unlocked condition; and a user operable opening button. The user operable opening button is slideable in a direction substantially parallel to a direction of movement of the latch assembly from a normal position to an opening position. When the locking mechanism is in the unlocked condition, movement of the opening button to the opening position moves the latch assembly from the latching position to the unlatching position. The opening button is operatively connected to the latch assembly by a spring member, such that when the locking mechanism is in the locked condition, movement of the opening button toward the opening position compresses the spring member without moving the latch assembly out of the latching position.
Patent NZ-600786-A (NZ)
Title: Proteasome inhibitors and processes for their preparation, purification and use
Inventor: ROEMMELE RENEE CAROLINE
IPC: C07F5/02
Filed: 2010-12-22
Abstract: 600786 Disclosed herein is a boronic ester of formula I, wherein the variables are defined in the specification, and the use thereof in a process for the preparation of a boronic acid, and a pharmaceutical composition comprising said boron acid. Embodiments of the boronic ester and acid include the following: (2S)-N-[(1R)-1-(1,3,6,2-dioxazaborocan-2-yl)-3-methylbutyl)-3-phenyl-2-(pyrazin-2-yl(formamido)propanamide, and [(1R)-1-[((2S,3R)-3-hydroxy-2-[((6-phenylpyridin-2-yl)carbonyl]aminol-1-oxobutyl]aminol-3-methylbutyl]boronic acid.
Patent NZ-606538-A (NZ)
Title: Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
Inventor: DUGI KLAUS
IPC: A61P3/10
Filed: 2010-01-07
Abstract: The present disclosure relates to the finding that certain DPP-4 inhibitors are particularly suitable for improving glycemic control in type 2 diabetes patients with inadequate glycemic control despite metformin therapy. In one embodiment the DPP-4 inhibitor is 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine and is used in combination with metformin. In a sub-embodiment the type 2 diabetes patient with inadequate glycemic control despite metformin therapy has HbA1c at baseline ≥ 9 %.
Patent NZ-608907-A (NZ)
Title: Melt-extruded solid dispersions containing an apoptosis-inducing agent
Inventor: LINDLEY DAVID J
IPC: A61K47/32
Filed: 2011-10-05
Abstract: The disclosure relates to a pro-apoptotic solid dispersion comprises, in essentially non-crystalline form, a Bcl-2 family protein inhibitory compound of formula (I) as defined herein, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises subjecting to elevated temperature the compound of formula (I), the water-soluble polymeric carrier and the surfactant, to provide an extrudable semi-solid mixture; extruding the semi-solid mixture; and cooling the resulting extrudate to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer or an immune or autoimmune disease.
Patent NZ-613726-A (NZ)
Title: Drinking vessels
Inventor: SABGA DONNA-MARIE
IPC: B65D51/24
Filed: 2012-02-02
Abstract: A beverage cup (30) with a closed compartment (60) containing an infusible material (50) such as tea and a drink- through lid (1) having a filter (6) to filter out the infusible material from the beverage (40) is disclosed. The filter comprises an area of the lid in which there is defined at least 20 apertures, the apertures being large enough to allow a beverage to be drank through the lid whilst obstructing passage of a filtrate. One embodiment allows the drinker to observer the beverage after being filtered before it is drunk.
Patent NZ-614631-A (NZ)
Title: A drip-retaining collar for a bottle
Inventor: LONG NATHAN
IPC: B65D23/06
Filed: 2012-01-25
Abstract: Disclosed are drip retaining collar (2) for a bottle and a product comprising a bottle having a drip retaining collar (2) mounted thereon. The disclosure notes that the drip retaining collar (2) sits on the neck of a bottle and aids in preventing staining of underlying surfaces when residual drops of liquid drip from the bottle after pouring. The drip retaining collar (2) comprises an annular drip collecting trough (10) arranged to collect drips running down the neck of the bottle. The annular trough (10) is partitioned into compartments (14). Each compartment (14) is sized and configured so that it can retain drips of liquid when the collar (2) is inverted. The drip retaining collar (2) further comprises a downwardly depending portion in the form of a skirt (4) which flared towards a lower end. The drip retaining collar (2) is moulded from a plastics material.
Patent NZ-614883-A (NZ)
Title: Pyrazolidin-3-one derivatives
Inventor: JAESCHKE GEORG
IPC: C07D487/04
Filed: 2012-04-23
Abstract: The present disclosure relates to ethynyl derivatives of formula I wherein X is N or CH; G is N or CH; with the proviso that maximum one of X or G can be nitrogen; R1 is phenyl or pyridyl, which are optionally substituted by halogen, lower alkyl or lower alkoxy; R2 is hydrogen, lower alkyl or may form together with R4 a C3-C6-cycloalkyl; R3, R3’, R4, R4’ are independently from each other hydrogen, lower alkyl or CF; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. It has now surprisingly been found that the compounds of general formula I are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5). Examples of compounds of formula (I) are: 2-[6-(2,5-difluoro-phenylethynyl)-pyridazin-3-yl]-5,5-dimethyl-pyrazolidin-3-one; 5,5-dimethyl-2-(5-phenylethynyl-pyrimidin-2-yl)-pyrazolidin-3-one; (RS)-1-(5-phenylethynyl-pyrimidin-2-yl)-tetrahydro-pyrrolo[1,2-b]pyrazol-2-one; 5,5-dimethyl-2-(5-phenylethynyl-pyridin-2-yl)-pyrazolidin-3-one and (RS)-5-isopropyl-2-(5-phenylethynyl-pyridin-2-yl)-pyrazolidin-3-one.
Patent NZ-618002-A (NZ)
Title: Dry powder vancomycin compositions and associated methods
Inventor: LORD JOHN
IPC: C07K9/00
Filed: 2012-05-21
Abstract: Dry powder vancomycin compositions and methods for administering and preparing such compositions. The compositions of the disclosure comprise vancomycin or a pharmaceutically acceptable salt thereof, and a hydrophobic amino acid, wherein the hydrophobic amino acid is present in an amount less than 50% by weight of the composition, and wherein the composition is a substantially amorphous dry powder. A composition of the present disclosure may be administered to a subject via pulmonary administration in an amount effective to treat and/or prevent a bacterial infection in the subject. Administration of an effective amount of a composition of the present disclosure may be particularly useful in treating a gram-positive bacterial infection in a subject suffering from pneumonia, cystic fibrosis, bronchiectasis, or other chronic lung disease with a bacterial infection of the subject’s airway and/or lung. The compositions may further comprise a hydrophobic amino acid which may be selected from the group consisting of: tryptophan, tyrosine, leucine, trileucine, and phenylalanine. The compositions may further comprise a carbohydrate bulking agent carbohydrate bulking agent which may be selected from the group consisting of: lactose, mannitol, trehalose, raffinose, and a maltodextrin.
Patent NZ-623134-A (NZ)
Title: Method of using controlled release tracers
Inventor: GUPTA D V SATYANARAYANA
IPC: C09K8/62
Filed: 2012-11-12
Abstract: Fluids produced from a fractured subterranean formation may be monitored by pumping into the well a fracturing fluid which contains a tracer. The method may be used to monitor produced hydrocarbons as well as produced water. The tracer may also be used in a sand control, frac pack or acid fracturing operation. The tracer is a component of a composite where it may be immobilized within a matrix (such as an emulsion) or porous particulate, onto a support or compressed with a binder into a solid particulate. The tracer may be slowly released from the composite.
Patent NZ-630535-A (NZ)
Title: Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
Inventor: YEUNG KAP-SUN
IPC: G01N33/68
Filed: 2014-03-13
Abstract: The present disclosure provides novel macrocyclic peptides of formula (I), which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Patent NZ-704832-A (NZ)
Title: Method and system for real-time keyword spotting for speech analytics
Inventor: GANAPATHIRAJU ARAVIND
IPC: G10L15/04
Filed: 2012-07-20
Abstract: A system and method are presented for real-time speech analytics in the speech analytics field. Real time audio is fed along with a keyword model, into a recognition engine. The recognition engine computes the probability of the audio stream data matching keywords in the keyword model. The probability is compared to a threshold where the system determines if the probability is indicative of whether or not the keyword has been spotted. Empirical metrics are computed and any false alarms are identified and rejected. The keyword may be reported as found when it is deemed not to be a false alarm and passes the threshold for detection.
Patent NZ-712300-A (NZ)
Title: Falz for use as a target for therapies to treat cancer
Inventor: KASHANI-SABET MOHAMMED
IPC: G01N33/574
Filed: 2014-03-15
Abstract: The disclosure provides methods for predicting and/or determining whether a subject has melanoma based on the level of expression of BPTF. The disclosure also provides methods for determining whether a cancer in a subject is progressing or regressing based upon the change of expression levels of BPTF between two time points. The disclosure further provides methods treat a subject with a cancer by administering a polynucleotide comprising an inhibitory BPTF nucleic acid and/or an agent that inhibits the expression or activity of BPTF.
Patent NZ-712553-A (NZ)
Title: Communication system and method
Inventor: ANDRES KUTT
IPC: H04M7/00
Filed: 2007-11-19
Abstract: Disclosed is a user terminal for establishing communication between a first and second user over a communications network. The second user is associated with contact information for a plurality of destination nodes. The user terminal is comprised of means for displaying a display to the first user, said display comprising a hyperlink containing an identity allocated to the contact information for the plurality of destination nodes from a set of available identities. The hyperlink does not contain the contact information of the second user. The user terminal also includes means for selecting said hyperlink and a client executed on the user terminal arranged to transmit a message to initiate communication over said communications network. The message comprises said identity and is received at a network node arranged to translate said identity to said contact information for the plurality of destination nodes, select one or more destination nodes from the plurality of destination nodes, and establish a connection over the communications network between the client and the selected one or more destination nodes using said contact information. When more than one destination node is selected, the connection is established with all of the destination nodes simultaneously and the client is connected to the first destination node answered by the user and connection to the remaining selected destination nodes is discontinued.
Patent NZ-718251-A (NZ)
Title: Piperazine derivatives and the use thereof as medicament
Inventor: GIOVANNINI RICCARDO
IPC: C07D413/14
Filed: 2014-10-15
Abstract: The present inventions relate to substituted piperazine derivatives of general formula (I) and to the manufacture of said compounds, pharmaceutical compositions comprising a compound according to general formula (I), and the use of said compounds for the treatment of various medical conditions related to glycine transporter-1 (GlyT1).
Patent NZ-726089-A (NZ)
Title: Antibody binding to fcrn for treating autoimmune diseases
Inventor: KIM SUNG WUK
IPC: G01N33/53
Filed: 2015-04-30
Abstract: The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmune diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.
Patent NZ-761522-A (NZ)
Title: Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
Inventor: HANSON GUNNAR
IPC: C07H21/00
Filed: 2011-05-27
Abstract: Disclosed is a process for preparing an oligonucleotide oligomer useful as antisense compounds, and comprising a modified cyclic intersubunit linkage, wherein the process comprises: (a) deprotecting the ring nitrogen of a solid-phase-supported morpholino subunit, wherein the morpholino subunit has the following structure (XXXI); (b) reacting the product of step (a) with a morpholino subunit of structure (XXXI) wherein Z is halo; (c) repeating n-2 iterations of steps (a) and (b), wherein n is 10 to 40; and (d) cleaving the product of steps (a), (b), and (c) from the solid-phase support; wherein PG is a protecting group, wherein PG is C7-C30 aralkyl; X is, at each occurrence, independently -N(CH3)2, -NR1R2, -NR8R9, -OR3 or a substituted piperazine, wherein at least one of the intersubunit linkages is linkage (B) wherein: i) R8 and R9 join to form an optionally substituted 5-18 membered mono or bicyclic heterocycle; or ii) R8, R9, or R3 may join with R10 to form an optionally substituted 5-7 membered heterocycle; and wherein the remaining substituents are as defined herein.
Patent PT-102161-A (PT)
Title: Simplified mechanism for tilting doors and large gates
Inventor: RAUTI GIUSEPPE
IPC: E06B3/38
Filed: 1998-05-28
Abstract: Mechanism consisting of two sets of a lever-arm system supported on three shafts, one of them being fixed to a helical spring, another is the centre of rotation and the other articulates on the door/large gate. The rolling path, fixed to the frame of the door/large gate allows a circular movement, a grooved pulley (sheave) fixed to the door/large gate running along it, providing a smooth and stable movement. <IMAGE>
Patent PT-109674-A (PT)
Title: Biossensor de aglutinina de vicia villosa para o antigénio tn associado a cancro
Inventor: MARIA LUÍSA SOARES DA SILVA
IPC: G01N33/574
Filed: 2016-10-10
Abstract: DESCREVE-SE A CONSTRUÇÃO, DESEMPENHO ANALÍTICO E VALIDAÇÃO DE UM BIOSSENSOR QUE EMPREGA A LECTINA DE VICIA VILLOSA (WA) COMO AGENTE DE BIO-RECONHECIMENTO, PARA A DETECÇÃO DO ANTIGÉNIO TN (GALNAC-AL-O-SER/THR) (5 PRESENTE EM GLICOPROTEÍNAS SECRETADAS PELAS CÉLULAS TUMORAIS DE CARCINOMAS PARA A CORRENTE SANGUÍNEA. O BIOSSENSOR DESENVOLVIDO CONSTITUI UMA FERRAMENTA ÚTIL PARA O ACOMPANHAMENTO DE DOENTES DIAGNOSTICADOS COM ALGUM TIPO DE CARCINOMA (DOMÍNIO TÉCNICO MEDICINA). REIVINDICA-SE O BIOSSENSOR AQUI DESCRITO COMO O PRIMEIRO COM AS CARACTERÍSTICAS DE SER CONSTRUÍDO COM BASE NUM ELÉCTRODO SERIGRAFADO DE OURO (I), SOBRE O QUAL SE IMOBILIZA A LECTINA VVA (3) ATRAVÉS DE UMA MONOCAMADA AUTO-ORGANIZADA (2) DE ÁCIDO 16-MERCAPTOHEXADECANÓICO. REIVINDICA-SE TAMBÉM O PROCESSO DE CONSTRUÇÃO, QUE INCLUI OS PASSOS SEQUENCIAIS, OS REAGENTES UTILIZADOS E RESPECTIVAS CONCENTRAÇÕES E VOLUMES E O PROCESSO DE MEDIÇÃO (6) POR ESPECTROSCOPIA DE IMPEDÂNCIA ELECTROQUÍMICA, USANDO A SONDA REDOX HEXACIANOFERRATO (II)/(III) (4). APRESENTAM-SE DESENHOS DO PROCESSO DE CONSTRUÇÃO E DOS GRÁFICOS QUE SE OBTÊM NA ANÁLISE DAS AMOSTRAS PELO BIOSSENSOR, BEM COMO OUTRAS FIGURAS E TABELA QUE REÚNEM RESULTADOS DO DESENVOLVIMENTO DO BIOSSENSOR.
Patent PT-109823-A (PT)
Title: Máquina de preparação de bebidas com descarga removível
Inventor: RUI MIGUEL NABEIRO
IPC: A47J31/44
Filed: 2016-12-30
Abstract: A PRESENTE INVENÇÃO REVELA UMA MÁQUINA (1) DE PREPARAÇÃO DE BEBIDAS, EM PARTICULAR BEBIDAS AROMÁTICAS COMO POR EXEMPLO CAFÉ TIPO EXPRESSO, COMPREENDENDO UMA CAIXA (2) DE MÁQUINA E MEIOS DE DESCARGA (7) INCLUINDO UMA CAIXA DE DESCARGA (71) QUE APRESENTA UMA RESPETIVA ABERTURA DE CAIXA (72) CONFINADA POR UMA PAREDE LATERAL (73) E POR UMA PAREDE DE BASE (74) QUE INCLUI PELO MENOS UMA, DE UM MODO PREFERIDO DUAS PASSAGENS DE DESCARGA (75) DISPOSTAS NUM LADO OPOSTO À REFERIDA ABERTURA DE CAIXA (72). A PRESENTE INVENÇÃO VISA PROPORCIONAR UMA MÁQUINA (1) DE PREPARAÇÃO DE BEBIDAS COM MEIOS DE DESCARGA (7) DE MAIS FUNCIONAIS, DE FÁCIL FIXAÇÃO À CAIXA (2) DE MÁQUINA. NESTE SENTIDO, DE ACORDO COM A PRESENTE INVENÇÃO, A REFERIDA CAIXA DE DESCARGA (71) COMPREENDE ELEMENTOS DE RETENÇÃO (76), DISPOSTOS DE UM MODO PREFERIDO EM POSIÇÕES MUTUAMENTE OPOSTAS NA REGIÃO DE PERÍMETRO DA REFERIDA ABERTURA DE CAIXA (72), SENDO QUE OS REFERIDOS ELEMENTOS DE RETENÇÃO (76) SÃO ADAPTADOS DE MODO A PROPORCIONAR UMA RETENÇÃO REMOVÍVEL AO LONGO DE UM PLANO LONGITUDINAL VERTICAL DA REFERIDA CAIXA DE DESCARGA (71) NA REFERIDA CAIXA (2) DE MÁQUINA, DE MODO QUE A REFERIDA ABERTURA DE CAIXA (72) É CONFINADA POR CIMA POR UMA PORÇÃO ORIENTADA PARA BAIXO DA REFERIDA CAIXA (2) DE MÁQUINA QUANDO RETIDA NESTA PELOS REFERIDOS ELEMENTOS DE RETENÇÃO (76), SENDO QUE OS REFERIDOS ELEMENTOS DE RETENÇÃO (76) SÃO ADAPTADOS DE MODO QUE PODEM PROPORCIONAR RETENÇÃO NA REFERIDA CAIXA (2) DE MÁQUINA E LIBERTAÇÃO DESTA POR MEIO DE ATUAÇÃO MANUAL DOS MESMOS SEM REQUERER O USO DE FERRAMENTAS PARA ESSE PROPÓSITO.